Further work is required to validate the spectrum of UNC5B genomic alterations, and in vivo experimental investigations are needed to validate the essential role of UNC5B in breast cancer, which could contribute to the development of precision medicine. This evidence concerns the gene UNC5B and breast carcinoma.